ServareGMP
banner
servaregmp.bsky.social
ServareGMP
@servaregmp.bsky.social
ServareGMP’s objective is to use its capabilities to meet the needs of the underserved, the neglected and the vulnerable
Servare's global impact and where we work
February 17, 2026 at 5:22 PM
Last year, we were proud to have a strategic partnership with Bio Usawa to establish advanced monoclonal antibody manufacturing capabilities in Africa, helping address the critical healthcare access gap affecting patients in low- and middle-income countries.

www.globenewswire.com/news-release...
Bio Usawa Biotechnology and ServareGMP Form Strategic Partnership to Advance Accessible Biotherapeutic Manufacturing in Africa
Strategic alliance brings advanced first-of-its-kind biotherapeutic production, workforce training, and rapid response capabilities to low- and...
www.globenewswire.com
February 13, 2026 at 8:09 PM
Our CEO, Gary Pierce, was recently featured in an article in @natbiotech.nature.com discussing the growing community of international non-profit organizations working to bring much needed life science innovations to underserved populations around the world!

www.nature.com/articles/s41...
Non-profits wade in where for-profit life science investment fears to tread - Nature Biotechnology
For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and ...
www.nature.com
February 10, 2026 at 7:12 PM
ServareGMP was established to help change this reality through three primary pathways:
February 6, 2026 at 6:56 PM
ServareGMP is a non-profit public benefit corporation dedicated to developing and manufacturing low-cost biologic medicines against infectious diseases, unmet needs and neglected diseases affecting the most vulnerable populations.
February 5, 2026 at 8:57 PM